Cite
HARVARD Citation
Baker, S. et al. (n.d.). 36: Progression-Free Survival and Local Control Following Stereotactic Ablative Radiotherapy for Up to Five Oligometastases: An Analysis from the Population-Based Phase II SABR-5 Trial. Radiotherapy and oncology. pp. S18-. [Online].